| Application no. and date | 22754752.8 (espacenet) (Federated) (European Patent Register), 20220727 | | Patent/reg. no. and date | DK/EP 4214240, 20241009 | | Publication date | 20230726 | | Priority no. and date | US 202163226118 P, 20210727 | | EP pub. no. and date |
EP 4214240 20230726 | | Effective date | | | Applicant/owner | AbbVie Inc., 1 N. Waukegan Road
North Chicago, IL 60064, US | | Applicant ref. no. | BB270555EPDK | | Inventor | MCCLUSKEY, Andrew, J.,
Chicago, IL 60064, US,
SCHMIDT PAUSTIAN, Amanda, M.,
Chicago, IL 60064, US,
SEAGAL, Jane,
Chicago, IL 60064, US,
WILSBACHER, Julie, L.,
Chicago, IL 60064, US | | Representative | Novagraaf Brevets, Bâtiment O2, 2 rue Sarah Bernhardt CS90017
F-92665 Asnières-sur-Seine cedex, FR | | Opponent | | | IPC Class | A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | | Title | ANTI-CCR8-ANTISTOFFER | | Int. application no. | US2022074214 | | Int. publication no. | WO2023010054 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
